|Hypothalamic hormones and cancer|
AV Schally, AM Comaru-Schally, A Nagy, M Kovacs, K Szepeshazi, ...
Frontiers in neuroendocrinology 22 (4), 248-291, 2001
|Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent|
A Nagy, AV Schally, P Armatis, K Szepeshazi, G Halmos, M Kovacs, ...
Proceedings of the National Academy of Sciences 93 (14), 7269-7273, 1996
|Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin|
A Nagy, AV Schally, G Halmos, P Armatis, RZ Cai, V Csernus, M Kovács, ...
Proceedings of the National Academy of Sciences 95 (4), 1794-1799, 1998
|Presence of receptors for bombesin/gastrin‐releasing peptide and mRNA for three receptor subtypes in human prostate cancers|
B Sun, G Halmos, AV Schally, X Wang, M Martinez
The Prostate 42 (4), 295-303, 2000
|High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers|
G Halmos, JM Arencibia, AV Schally, R Davis, DG Bostwick
The Journal of urology 163 (2), 623-629, 2000
|Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers|
Z Rekasi, T Czompoly, AV Schally, G Halmos
Proceedings of the National Academy of Sciences 97 (19), 10561-10566, 2000
|Peptide analogs in the therapy of prostate cancer|
AV Schally, AM Comaru‐Schally, A Plonowski, A Nagy, G Halmos, ...
The prostate 45 (2), 158-166, 2000
|Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression|
G Halmos, JL Wittliff, AV Schally
Cancer research 55 (2), 280-287, 1995
|The role of indoleamine-2, 3-dioxygenase in cancer development, diagnostics, and therapy|
L Hornyák, N Dobos, G Koncz, Z Karányi, D Páll, Z Szabó, G Halmos, ...
Frontiers in immunology 9, 151, 2018
|The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues|
A Havt, AV Schally, G Halmos, JL Varga, GL Toller, JE Horvath, ...
Proceedings of the National Academy of Sciences 102 (48), 17424-17429, 2005
|Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro|
Y Qin, T Ertl, RZ Cai, G Halmos, AV Schally
Cancer research 54 (4), 1035-1041, 1994
|Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin|
A Nagy, P Armatis, RZ Cai, K Szepeshazi, G Halmos, AV Schally
Proceedings of the National Academy of Sciences 94 (2), 652-656, 1997
|Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix|
G Halmos, AV Schally, J Pinski, M Vadillo-Buenfil, K Groot
Proceedings of the National Academy of Sciences 93 (6), 2398-2402, 1996
|Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II …|
A Jungwirth, J Pinski, G Galvan, G Halmos, K Szepeshazi, RZ Gai, ...
European Journal of Cancer 33 (7), 1141-1148, 1997
|Inhibition of growth of MKN45 human gastric‐carcinoma xenografts in nude mice by treatment with bombesin/gastrin‐releasing‐peptide antagonist (RC‐3095) and somatostatin …|
J Pinski, G Halmos, T Yano, K Szepeshazi, Y Qin, T Ertl, AV Schally
International journal of cancer 57 (4), 574-580, 1994
|Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone|
M Zarandi, JE Horvath, G Halmos, J Pinski, A Nagy, K Groot, Z Rekasi, ...
Proceedings of the National Academy of Sciences 91 (25), 12298-12302, 1994
|Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone|
G Halmos, AV Schally, JL Varga, A Plonowski, Z Rekasi, T Czompoly
Proceedings of the National Academy of Sciences 97 (19), 10555-10560, 2000
|The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers|
B Sun, AV Schally, G Halmos
Regulatory peptides 90 (1-3), 77-84, 2000
|Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone|
M Miyazaki, A Nagy, AV Schally, N Lamharzi, G Halmos, K Szepeshazi, ...
Journal of the National Cancer Institute 89 (23), 1803-1809, 1997
|Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone|
J Pinski, AV Schally, K Groot, G Halmos, K Szepeshazi, M Zarandi, ...
JNCI Journal of the National Cancer Institute 87 (23), 1787-1794, 1995